Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 122,835 | 148,835 | 160,219 | 176,007 | -81,036 |
| Depreciation Amortization | 237 | 180 | 128 | 75 | 307 |
| Accounts receivable | 142 | 142 | 142 | -882 | N/A |
| Accounts payable and accrued liabilities | 1,703 | -2,284 | -4,518 | -2,277 | 2,334 |
| Other Working Capital | -16,815 | -22,144 | -21,442 | -16,503 | 21,819 |
| Other Operating Activity | 10,510 | 5,881 | 6,954 | 4,479 | 4,992 |
| Operating Cash Flow | $118,612 | $130,610 | $141,482 | $160,899 | $-51,584 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 35,039 |
| PPE Investments | -184 | -22 | N/A | -12 | -127 |
| Purchase Of Investment | -1,632 | -1,632 | -1,584 | N/A | N/A |
| Purchase Sale Intangibles | -5 | -5 | -12 | N/A | -263 |
| Other Investing Activity | -5 | -5 | -12 | 0 | -264 |
| Investing Cash Flow | $-1,821 | $-1,659 | $-1,595 | $-12 | $34,648 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 925 | 816 | 267 | 151 | 47,236 |
| Other Financing Activity | -21 | -21 | -21 | -21 | -163 |
| Financing Cash Flow | $904 | $795 | $246 | $130 | $47,073 |
| Beginning Cash Position | 72,034 | 72,034 | 72,034 | 72,034 | 41,897 |
| End Cash Position | 189,728 | 201,780 | 212,167 | 233,051 | 72,034 |
| Net Cash Flow | $117,694 | $129,746 | $140,133 | $161,017 | $30,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | 118,612 | 130,610 | 141,482 | 160,899 | -51,584 |
| Capital Expenditure | -184 | -22 | 0 | -12 | -127 |
| Free Cash Flow | 118,428 | 130,588 | 141,482 | 160,888 | -51,711 |